Kal, 46, brings more than 20 years of pharmaceutical, food and contract research experience to the company.
Before joining NIZO food research, Kal spent three years at Darling Ingredients as CEO of Rousselot, and held executive positions at Royal DSM NV with a focus on ingredients for the global pharmaceutical, infant nutrition and food industries.
Kal holds an MSc in Bio-organic Polymers from Leiden University.
Opportunity for future growth
His predecessor, Ad Juriaanse, who was CEO of NIZO food research since 1995, retired at the end of July 2016. Dr Juriaanse led NIZO’s transformation from a scientific institute for the Dutch dairy industry to an independent commercial contract research organization for the global food and health industries.
Kal said that research in health and food is converging.
“The pharmaceutical industry is looking at the impact of food components, while the food industry is building more expertise on the health effects of its products,” Kal said.
“Therefore, companies increasingly rely on areas that fit NIZO’s expertise, for example in protein, microbiome and related big-data analytics. As a result, there will be ample opportunities to build our future growth.”